Molecular Mechanisms of Glutamate Toxicity in Parkinson’s Disease
Ji Wang(Second Affiliated Hospital of Guangzhou Medical University), Shaogang Qu(Ganzhou People's Hospital)
Cited by 219
Related Papers
Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxidant Protein in Parkinson Disease Models
|Frontiers in Molecular Neuroscience|2018|108
Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson’s disease
|Cell Death and Disease|2017|63
Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway
|Experimental and Therapeutic Medicine|2018|55
Induction of Apoptosis by Hypertension Via Endoplasmic Reticulum Stress
|Kidney & Blood Pressure Research|2015|34